Literature DB >> 20121407

Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection.

Barbara M Schulte1, Judith Bakkers, Kjerstin H W Lanke, Willem J G Melchers, Ciska Westerlaken, Wil Allebes, Henk-Jan Aanstoot, G Jan Bruining, Gosse J Adema, Frank J M Van Kuppeveld, Jochem M D Galama.   

Abstract

Previous studies have shown that enteroviral RNA can be detected in blood at the onset of type 1 diabetes (T1D). The infection may play a role in triggering T1D and genetic host factors may contribute to this process. We investigated (1) whether enterovirus is present at the onset of T1D in peripheral blood mononuclear cells (PBMC), plasma, throat, or stool, and (2) whether enteroviral presence is linked with HLA-DR type and/or polymorphisms in melanoma differentiation-associated gene 5 (MDA5) and 2'-5' oligoadenylate synthetase 1 (OAS1), factors of antiviral immunity. To this end, PBMC, plasma, throat, and stool samples from 10 T1D patients and 20 unrelated controls were tested for the presence of enteroviruses (RT-PCR), for HLA-DR type, and polymorphisms in MDA5 and OAS1. Enterovirus RNA was detected in PBMC of 4/10 T1D patients, but none of 20 controls. Plasma was positive in 2/10 T1D patients and none of 20 controls, suggesting that enteroviruses found at the onset of T1D are mainly present in PBMC. All throat samples from positive T1D patients were virus-negative and only 1 fecal sample was positive. The negative results for all throat and most stool samples argues against acute infection. Enterovirus presence was linked with HLA-DR4, but not with polymorphisms in MDA5 or OAS1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20121407     DOI: 10.1089/vim.2009.0072

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  33 in total

Review 1.  Infection as a cause of type 1 diabetes?

Authors:  Urs Christen; Christine Bender; Matthias G von Herrath
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

2.  Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.

Authors:  Magloire Pandoua Nekoua; Antoine Bertin; Famara Sane; Enagnon Kazali Alidjinou; Delphine Lobert; Jacques Trauet; Christine Hober; Ilka Engelmann; Kabirou Moutairou; Akadiri Yessoufou; Didier Hober
Journal:  Cell Mol Life Sci       Date:  2019-06-06       Impact factor: 9.261

Review 3.  Interferon alpha: The key trigger of type 1 diabetes.

Authors:  Angela Lombardi; Effie Tsomos; Sara S Hammerstad; Yaron Tomer
Journal:  J Autoimmun       Date:  2018-08-14       Impact factor: 7.094

Review 4.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies.

Authors:  L C Stene; M Rewers
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

5.  Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with a high genetic risk of type 1 diabetes: the MIDIA study.

Authors:  Ondrej Cinek; Lars C Stene; Lenka Kramna; German Tapia; Sami Oikarinen; Elisabet Witsø; Trond Rasmussen; Peter A Torjesen; Heikki Hyöty; Kjersti S Rønningen
Journal:  Diabetologia       Date:  2014-07-23       Impact factor: 10.122

Review 6.  Potential role of type I interferon in the pathogenic process leading to type 1 diabetes.

Authors:  Natasha Qaisar; Agata Jurczyk; Jennifer P Wang
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-04       Impact factor: 3.243

Review 7.  Virus infections and type 1 diabetes risk.

Authors:  Merja Roivainen; Karin Klingel
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

Review 8.  Protection against or triggering of Type 1 diabetes? Different roles for viral infections.

Authors:  Tobias Boettler; Matthias von Herrath
Journal:  Expert Rev Clin Immunol       Date:  2011-01       Impact factor: 4.473

Review 9.  Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?

Authors:  Urs Christen; Matthias G von Herrath
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

Review 10.  Viral infections in type 1 diabetes mellitus--why the β cells?

Authors:  Anne Op de Beeck; Decio L Eizirik
Journal:  Nat Rev Endocrinol       Date:  2016-03-29       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.